Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | EviCore by Evernorth | Tzield (teplizumab-mzwv) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Trogarzo (ibalizumab-uiyk injection) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Triptodur (triptorelin extended-release suspension) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Treprostinil Injection (Remodulin, generic) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Tremfya Intravenous (guselkumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Tocilizumab Intravenous (Actemra, Avtozma, Tyenne, Tofidence) non-oncology | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Tezspire (tezepelumab-ekko) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Tepezza (teprotumumab-trbw) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Synagis (palivizumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Syfovre (pegcetacoplan injection) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Susvimo (ranibizumab intravitreal injection via ocular implant) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Supprelin LA (histrelin acetate subcutaneous implant) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Sunlenca (lenacapavir) Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cutaquig, Cuvitru, Gammagard Liquid, Gammagard Liquid ERC, Gammaked, Gamunex-C, Hizentra, HyQvia, Xembify) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Spravato (esketamine nasal spray) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Spinraza (nusinersen) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Spevigo (spesolimab-sbzo) Intravenous Injection | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Skyrizi Intravenous (risankizumab-rzaa) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Simponi Aria (golimumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Signifor LAR (pasireotide) Injectable Suspension | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Sevenfact (coagulation factor VIIa [recombinant]-jncw) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Scenesse (afamelanotide) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Saphnelo (anifrolumab-fnia) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Rystiggo (rozanolixizumab-noli) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Ruconest (recombinant C1 esterase inhibitor) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Roctavian (valoctocogene roxaparvovec-rvox) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Rituximab (Rituxan, Ruxience, Truxima, Riabni) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Revcovi (elapegademase-lvlr) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Repatha (evolocumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Reclast (zoledronic acid) Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Rebyota (fecal microbiota, live-jslm) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Reblozyl (luspatercept-aamt) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Ranibizumab (Lucentis, Byooviz, and Cimerli) Injection | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Qalsody (tofersen intrathecal injection) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Purified Cortrophin Gel (repository corticotropin injection) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Preface to Medical Drug Management Guidelines New Medical Drug / Indication | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Pombiliti (cipaglucosidase alfa-atga) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | PiaSky (crovalimab-akkz) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Papzimeos (zopapogene imadenovec-drba) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Oxlumo (lumasiran) Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Orencia Intravenous (abatacept) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Onpattro (patisiran) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Omvoh (mirikizumab-mrkz) Intravenous | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Octreotide Acetate Long-acting Products (Sandostatin LAR Depot, generic) - non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Ocrevus (ocrelizumab) Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Nulojix (belatacept) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Nulibry (fosdenopterin) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Nucala (mepolizumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Nplate (romiplostim) Non-oncology | New policy |